Download | < Back |
23 Apr 2021 | |
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Doxepin Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg, 75 mg and 100 mg.<BR> <BR> Please find enclosed herewith our press release.<BR> <BR> We request you to kindly take the same on record.<BR> | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |